Literature DB >> 9768691

Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg-->Cys at codon 120 (R120C).

C Flück1, J Deladoey, K Rutishauser, A Eblé, U Marti, W Wu, P E Mullis.   

Abstract

As pituitary function depends on the integrity of the hypothalamic-pituitary axis, any defect in the development and organogenesis of this gland may account for a form of combined pituitary hormone deficiency (CPHD). A mutation in a novel, tissue-specific, paired-like homeodomain transcription factor, termed Prophet of Pit-1 (PROP1), has been identified as causing the Ames dwarf (df) mouse phenotype, and thereafter, different PROP1 gene alterations have been found in humans with CPHD. We report on the follow-up of two consanguineous families (n = 12), with five subjects affected with CPHD (three males and two females) caused by the same nucleotide C to T transition, resulting in the substitution of Arg-->Cys in PROP1 at codon 120. Importantly, there is a variability of phenotype, even among patients with the same mutation. The age at diagnosis was dependent on the severity of symptoms, ranging from 9 months to 8 yr. Although in one patient TSH deficiency was the first symptom of the disorder, all patients became symptomatic by exhibiting severe growth retardation and failure to thrive, which was mainly caused by GH deficiency (n = 4). The secretion of the pituitary-derived hormones (GH, PRL, TSH, LH, and FSH) declined gradually with age, following a different pattern in each individual; therefore, the deficiencies developed over a variable period of time. All of the subjects entered puberty spontaneously, and the two females also experienced menarche and periods before a replacement therapy was necessary.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9768691     DOI: 10.1210/jcem.83.10.5172

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  35 in total

Review 1.  Other transcription factors and hypopituitarism.

Authors:  Laurie E Cohen; Sally Radovick
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

2.  Pituitary size fluctuation in long-term MR studies of PROP1 deficient patients: A persistent pathophysiological mechanism?

Authors:  A Voutetakis; A Sertedaki; S Livadas; P Xekouki; I Bossis; C Dacou-Voutetakis; M I Argyropoulou
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

Review 3.  Hormonal regulation of longevity in mammals.

Authors:  Holly M Brown-Borg
Journal:  Ageing Res Rev       Date:  2007-02-20       Impact factor: 10.895

Review 4.  The role of homeodomain transcription factors in heritable pituitary disease.

Authors:  Kelly L Prince; Emily C Walvoord; Simon J Rhodes
Journal:  Nat Rev Endocrinol       Date:  2011-07-26       Impact factor: 43.330

Review 5.  Genetic aspects of central hypothyroidism.

Authors:  R Collu
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

Review 6.  Phenotype-genotype correlations in congenital isolated growth hormone deficiency (IGHD).

Authors:  Kyriaki S Alatzoglou; Mehul T Dattani
Journal:  Indian J Pediatr       Date:  2011-12-03       Impact factor: 1.967

7.  Notch signaling in postnatal pituitary expansion: proliferation, progenitors, and cell specification.

Authors:  Leah B Nantie; Ashley D Himes; Dan R Getz; Lori T Raetzman
Journal:  Mol Endocrinol       Date:  2014-03-27

8.  Detection of genetic hypopituitarism in an adult population of idiopathic pituitary insufficiency patients with growth hormone deficiency.

Authors:  Helena Filipsson Nyström; Alexandru Saveanu; Edna J L Barbosa; Anne Barlier; Alain Enjalbert; Camilla Glad; Jenny Palming; Gudmundur Johannsson; Thierry Brue
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

Review 9.  Magnetic resonance imaging of the hypothalamus-pituitary unit in childrensuspected of hypopituitarism: who, how and when toinvestigate.

Authors:  M Maghnie; S Ghirardello; E Genovese
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

Review 10.  The molecular basis of hypopituitarism.

Authors:  Christopher J Romero; Suzana Nesi-França; Sally Radovick
Journal:  Trends Endocrinol Metab       Date:  2009-10-23       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.